Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
634 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (365)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04319874 | Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma | unknown | Phase 2 | 80 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Mar 30, 2020 | clinicaltrials |
| NCT04294511 | Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma | unknown | Phase 2 | 75 | Sun Yat-sen UniversityOTHER | 1 | Mar 4, 2020 |
| clinicaltrials |
| NCT03168061 | Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma | unknown | Phase 1 / Phase 2 | 150 | NanoCarrier Co., Ltd.INDUSTRY | 1 | Feb 28, 2020 | clinicaltrials |
| NCT04239443 | Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer | unknown | Phase 2 | 120 | Hunan Cancer HospitalOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT03139487 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY) | unknown | Phase 2 | 176 | Asan Medical CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT02856048 | Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer(PRESOV) | unknown | Phase 2 / Phase 3 | 11 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT03638206 | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | unknown | Phase 1 / Phase 2 | 73 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Dec 11, 2019 | clinicaltrials |
| NCT01883518 | Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma(ADCVCTAST) | unknown | Phase 1 / Phase 2 | 48 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Nov 20, 2019 | clinicaltrials |
| NCT03469804 | Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma(KAPKEY) | unknown | Phase 2 | 17 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT04126811 | Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma | unknown | Phase 2 | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Oct 15, 2019 | clinicaltrials |
| NCT04126993 | Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma | unknown | Phase 2 | 80 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Oct 15, 2019 | clinicaltrials |
| NCT03946943 | Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma | unknown | Phase 2 | 25 | Di WuOTHER | 1 | Jul 10, 2019 | clinicaltrials |
| NCT03815474 | Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients(ALTER-S005) | unknown | Phase 2 | 47 | Liaoning Cancer Hospital & InstituteOTHER | 1 | Jul 9, 2019 | clinicaltrials |
| NCT03816475 | Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)(LIPOMYX) | unknown | Phase 2 | 35 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Jun 17, 2019 | clinicaltrials |
| NCT02409576 | Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas(NKEXPSARC) | unknown | Phase 1 / Phase 2 | 20 | National University Hospital, SingaporeOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03880695 | Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma(ALTER-S001) | unknown | Phase 2 | 48 | Peking University People's HospitalOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT03416517 | Anlotinib and Irinotecan for Ewing Sarcoma | unknown | Phase 1 / Phase 2 | 47 | Peking University People's HospitalOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT01337401 | A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)(CASPS) | unknown | Phase 2 | 36 | Institute of Cancer Research, United KingdomOTHER | 3 | Jan 24, 2019 | clinicaltrials |
| NCT03792542 | Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy | unknown | Phase 2 | 44 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jan 3, 2019 | clinicaltrials |
| NCT03219671 | Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS) | unknown | Phase 2 | 20 | Alona ZerOTHER | 1 | Dec 26, 2018 | clinicaltrials |
| NCT01552239 | Preoperative Radiotherapy for Sarcomas of the Extremities With Intensity-Modulation, Image-Guidance and Small Safety-margins(PREMISS) | unknown | Phase 2 | 50 | Technical University of MunichOTHER | 1 | Oct 16, 2018 | clinicaltrials |
| NCT02942537 | Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment(MYOMIC1) | unknown | Phase 2 / Phase 3 | 36 | Karolinska InstitutetOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT03676985 | A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma | unknown | Phase 1 / Phase 2 | 15 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Sep 26, 2018 | clinicaltrials |
| NCT01807468 | Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors | unknown | Phase 2 | 12 | Samsung Medical CenterOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT02784015 | Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma | unknown | Phase 2 | 41 | Samsung Medical CenterOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03512834 | Paclitaxel-Avelumab for Angiosarcoma(ASAP) | unknown | Phase 2 | 32 | Sung Yong OhOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT03550703 | Open Label Immunotherapy of Myoma(V3-myoma) | unknown | Phase 2 | 30 | Immunitor LLCINDUSTRY | 1 | Jul 6, 2018 | clinicaltrials |
| NCT03539172 | Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study(RASS) | unknown | Phase 2 | 61 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT03509168 | The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.(MM) | unknown | Phase 2 / Phase 3 | 46 | Makerere UniversityOTHER | 1 | Apr 30, 2018 | clinicaltrials |
| NCT03390946 | Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma | unknown | Phase 2 | 23 | Byung-Kiu ParkOTHER_GOV | 1 | Jan 9, 2018 | clinicaltrials |
| NCT02982486 | A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | unknown | Phase 2 | 60 | Assaf-Harofeh Medical CenterOTHER_GOV | 0 | Nov 1, 2017 | clinicaltrials |
| NCT03096912 | A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma | unknown | Phase 2 | 30 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Oct 25, 2017 | clinicaltrials |
| NCT03171389 | POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST(POETIG) | unknown | Phase 2 | 81 | Sebastian BauerOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03163381 | Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study. | unknown | Phase 2 | 40 | Henan Cancer HospitalOTHER_GOV | 1 | May 23, 2017 | clinicaltrials |
| NCT03121846 | Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy | unknown | Phase 2 | 80 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 22, 2017 | clinicaltrials |
| NCT02449343 | Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203) | unknown | Phase 2 / Phase 3 | 233 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Apr 25, 2017 | clinicaltrials |
| NCT03063983 | Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma(GLATO2017) | unknown | Phase 2 | 158 | Grupo de Apoio ao Adolescente e a Crianca com CancerOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT03064243 | A Phase II Study of Apatinib in STS Patients | unknown | Phase 2 | 53 | Shanghai Jiao Tong University Affiliated Sixth People's HospitalOTHER | 0 | Feb 27, 2017 | clinicaltrials |
| NCT02571829 | A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma | unknown | Phase 2 | 30 | Hadassah Medical OrganizationOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT02812654 | Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment | unknown | Phase 2 | 70 | AC Camargo Cancer CenterOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT02732678 | Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)(PROPAN) | unknown | Phase 1 / Phase 2 | 24 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Apr 11, 2016 | clinicaltrials |
| NCT02587169 | Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum(GEIS-27) | unknown | Phase 1 / Phase 2 | 40 | Broto, Javier Martín, M.D.INDIV | 1 | Oct 27, 2015 | clinicaltrials |
| NCT01904565 | Hyperthermia and Proton Therapy in Unresectable Soft Tissue Sarcoma(HYPROSAR) | unknown | Phase 1 / Phase 2 | 26 | Kantonsspital AarauOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT01380275 | Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas. | unknown | Phase 2 | 35 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01002092 | A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma | unknown | Phase 2 | 160 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Sep 3, 2014 | clinicaltrials |
| NCT00410462 | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | unknown | Phase 2 | 118 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00084695 | Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases | unknown | Phase 2 | 25 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00003718 | Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma | unknown | Phase 2 | 25 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003719 | Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma | unknown | Phase 2 | 27 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00017446 | CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | unknown | Phase 2 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Mar 30, 2020source: clinicaltrials